ENERGIZE: A GLOBAL PHASE 3 STUDY OF MITAPIVAT DEMONSTRATING EFFICACY AND SAFETY IN ADULTS WITH ALPHA- OR BETA-NON¿TRANSFUSION-DEPENDENT THALASSEMIA AT Taher; H Al-Samkari; Y Aydinok; M Besser; G Luna; S Gheuens; A Glenthj; AS Goh; A Kattamis; SR Loggetto; KM Musallam; P Ricchi; E Salido-Fiérrez; S Sheth; V Viprakasit; MD Cappellini; KH Kuo;

IMPROVEMENTS IN FATIGUE AND 6-MINUTE WALK TEST IN ADULTS WITH ALPHA- OR BETA-NON¿TRANSFUSION-DEPENDENT THALASSEMIA: THE PHASE 3 ENERGIZE TRIAL OF MITAPIVAT KH Kuo; H Al-Samkari; Y Aydinok; M Besser; S Gheuens; G Luna; A Glenthj; AS Goh; A Kattamis; SR Loggetto; KM Musallam; P Ricchi; E Salido-Fiérrez; S Sheth; V Viprakasit; MD Cappellini; AT Taher;

LONG-TERM EFFICACY AND SAFETY OF THE ORAL PYRUVATE KINASE ACTIVATOR MITAPIVAT IN ADULTS WITH NON¿TRANSFUSION-DEPENDENT ALPHA- OR BETA-THALASSEMIA KH Kuo; DM Layton; A Lal; H Al-Samkari; J Bhatia; PA Kosinski; B Tong; M Lynch; K Uhlig; EP Vichinsky;